# The Role of Cardiac Biomarkers in Prediction of Outcome in Atrial Fibrillation Patients Undergoing Catheter Ablation

> **NCT01148914** · — · COMPLETED · sponsor: **Texas Cardiac Arrhythmia Research Foundation** · enrollment: 48 (actual)

## Conditions studied

- Atrial Fibrillation

## Interventions

- **OTHER:** Inflammatory biomarkers

## Key facts

- **NCT ID:** NCT01148914
- **Lead sponsor:** Texas Cardiac Arrhythmia Research Foundation
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2010-06
- **Primary completion:** 2012-04
- **Final completion:** 2012-04
- **Target enrollment:** 48 (ACTUAL)
- **Last updated:** 2012-06-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01148914

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01148914, "The Role of Cardiac Biomarkers in Prediction of Outcome in Atrial Fibrillation Patients Undergoing Catheter Ablation". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT01148914. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
